The Super-Mushroom Blend: four fungi, one molecule

The Super-Mushroom Blend is the name 4Life gives to the four fungal ingredients in 4Life Transfer Factor® Max: shiitake, Cordyceps sinensis, maitake fruiting body extract and Agaricus blazeii. They sit in the formula alongside IP-6, baker’s yeast, oats, zinc, vitamin C and vitamin D — the supporting cast around the 900 mg of 4Life Transfer Factor that gives the product its name.

Most ingredient pages treat a list like that as four separate facts to be recited one after another. It is more useful, and more accurate, to read it as one fact repeated four times. These four fungi are not four different ideas about immunity. They are four sources of the same class of molecule, and that molecule has a receptor waiting for it on the surface of human white blood cells.

One clarification before the science, because the names get mixed up constantly in this category. This blend is not Cordyvant™. Cordyvant is 4Life’s branded proprietary polysaccharide complex in Transfer Factor Plus Tri-Factor Formula — a different product, with a longer ingredient list that reaches well beyond mushrooms. 4Life’s published materials for Max call its four fungi the Super-Mushroom Blend. That is the company’s own term for this product, so it is the term used throughout this page.

What is actually in the blend

Here are the four, with the name that appears in product information set beside the name a mycologist would currently use. The gap between those two columns is not pedantry — it is the single most practical thing on this page for anyone trying to look these organisms up.

One molecule, four sources

A beta-glucan is a chain of glucose units linked together in a particular way. In fungi the usual architecture is a backbone of beta-(1,3) links carrying side branches hung off beta-(1,6) links, which produces a branched rather than a straight molecule. It is structural material. A fungal cell wall uses beta-glucan roughly the way a plant uses cellulose — to hold its shape.

Two things follow, and they are the whole reason this molecule matters to immunology. Humans do not build beta-glucan, and humans cannot digest it. It passes through the body as something recognisably not-us and, more specifically, recognisably fungal. A molecule that is common in the microbial world, absent from human tissue and chemically stable is exactly the kind of marker an immune system can afford to build a permanent detector for — the same logic that governs the innate recognition described in our piece on modulation versus boosting.

The receptor that turned folklore into biology

For most of the twentieth century, the claim that mushrooms had something to do with immune function rested on tradition, on animal experiments and on isolated polysaccharide fractions that visibly did something in a dish. What was missing was the connection: a named human protein that binds this material and reports it.

That protein is Dectin-1. Brown and Gordon published it in Nature in 2001 under a title as plain as its finding, “A new receptor for beta-glucans.” They found it by screening a macrophage gene library with zymosan — a beta-glucan-rich preparation of baker’s yeast cell wall that immunologists had been using as a generic immune stimulant for decades without knowing what in it was being seen, or by what. Subsequent work established Dectin-1 as a pattern-recognition receptor that signals on its own rather than borrowing another receptor’s machinery, drives cytokine production, and is required for controlling fungal infection.

It sits chiefly on myeloid cells — macrophages, dendritic cells, neutrophils — and not on the lymphocytes described in our immune cells primer. That is a useful detail, because it locates every honest discussion of dietary beta-glucan in the innate, first-responder half of the immune system rather than the antibody-and-memory half.

What Dectin-1 does not do is make any product work. A receptor existing in human tissue is a fact about human beings. Whether a given quantity of a given mushroom extract in a capsule engages it meaningfully is a separate question, and one this article deliberately leaves open rather than answering with enthusiasm.*

The four, one at a time

Shiitake — Lentinula edodes

The most familiar mushroom on the list has the most confusing paper trail. Miles Joseph Berkeley described it in 1877 as Agaricus edodes, filing shiitake in the same genus as the common button mushroom; it was moved to Lentinus, and David Pegler placed it in Lentinula in 1976, where it has stayed. Older labels and older papers still say Lentinus edodes.

Shiitake is also the source of lentinan, a purified beta-(1,3)-glucan isolated and characterised in Japan from the 1960s onward, which was subsequently developed there as an injected pharmaceutical adjunct rather than a supplement ingredient. That distinction does a lot of work. A purified polysaccharide, given by injection, at a controlled dose, in a hospital, is not a culinary mushroom in a capsule, and the literature on the first does not transfer to the second. Anyone quoting lentinan studies at you about a supplement has skipped that step.

Cordyceps — Ophiocordyceps sinensis

The strangest organism in the formula is a parasite. In the wild, the fungus known in Chinese as dong chong xia cao — winter worm, summer grass — infects moth larvae on the Tibetan Plateau, consumes the caterpillar from inside, and in spring sends a slender fruiting body up through the soil. Molecular phylogenetics later showed the genus Cordyceps was not a single natural group, and this species was transferred to Ophiocordyceps.

Then the commercial reality, which reputable manufacturers do not hide and consumers are rarely told. Wild O. sinensis is among the most expensive biological commodities on earth. Practically all cordyceps material in supplements is instead fermented mycelium grown in tanks — most famously Cs-4, from a strain isolated in 1982 by the Institute of Chinese Materia Medica from samples collected in Yunnan and identified as Paecilomyces hepiali. Read “Cordyceps sinensis” on any label as a statement about fungal lineage and cultured material, not about a harvested caterpillar.

Maitake — Grifola frondosa

The one name on the list that has never moved. Maitake means dancing mushroom; in English-speaking woods it is hen of the woods, a ruffled bracket that grows in large clusters at the base of oaks. In 1984 Nanba and colleagues identified a polysaccharide fraction in both its mycelium and its fruiting body that strongly stimulated macrophages in the laboratory, which became known as the D-fraction and was later refined into the more purified MD-fraction; grifolan is another named beta-glucan from the same species.

The same caution applies as with lentinan, and for the same reason. D-fraction is a prepared laboratory fraction. Transfer Factor Max contains maitake as a fruiting body extract. Those are different preparations, and only one of them has a research literature attached to it.

Agaricus — Agaricus subrufescens

The youngest member of the group as a studied organism, and the one with the most tangled name. It was collected near the village of Piedade, in Sao Paulo state, Brazil, and sent to Japan in 1965 for study; in 1967 the Belgian botanist Paul Heinemann identified it as Agaricus blazei Murrill, a species originally described from Florida. That identification did not hold. The Brazilian mushroom is a different organism, and its oldest valid name is Agaricus subrufescens. For a period it also circulated as Agaricus brasiliensis. It is himematsutake in Japan and cogumelo do sol in Brazil.

This is not trivia. Three names across five decades of publication means anyone reading the agaricus literature has to establish, study by study, which organism was actually in the flask.

Why baker’s yeast and oats are on the same ingredient list

Two non-mushroom entries in Transfer Factor Max belong to this discussion, one of them squarely and one of them only by name.

Baker’s yeast — Saccharomyces cerevisiae — has a cell wall built from the same branched beta-glucan as the mushrooms, and it is the historical source of zymosan, the very preparation that led to Dectin-1. In an ingredient list that already contains four fungi, yeast is not a departure from the theme. It is the theme, stated plainly.

Oats are the instructive exception. Oats contain beta-glucan too, but a structurally different molecule: the cereal form is largely linear, with beta-(1,4) links interrupted by beta-(1,3) links, rather than the branched beta-(1,3/1,6) architecture of fungi. Same family name, different shape, different research literature — the oat literature is largely about viscosity, digestion and cholesterol. Results from one should never be quoted about the other, and this page does not do so.

What this article does not claim

Five things, stated in the open rather than buried at the bottom in small type.

• No amounts. The Super-Mushroom Blend’s per-ingredient milligram figures are not published by 4Life, and nothing here estimates them. In mushroom science, dose and preparation are the whole argument — so the absence of those numbers is a genuine limit on what anyone outside the company can conclude, including us.
• Isolate research does not transfer. Lentinan, D-fraction and grifolan are purified fractions studied at controlled doses and, in lentinan’s case, by injection. This article cites that history to explain where the interest in these species came from, and for no other purpose.
• A receptor is not a result. Dectin-1 binds beta-glucan in human tissue whether or not anyone ever takes a supplement. Mechanism explains why a category is plausible; it is not evidence that a specific product does anything.
• Species identity is genuinely uncertain in places. The agaricus naming history in particular means published studies under three names may not all concern the same organism.
• No disease claims of any kind. Nothing here says that any mushroom, any beta-glucan, or any product diagnoses, treats, cures or prevents any disease.*

Which of this has the Transfer Factor Max research measured?

Almost none of it, and the honest version of that sentence is short. The three studies associated with the product — Yu 2024 on immune-related biomarkers, Gardner 2026 on stem cell mobilisation, Jensen 2026 on neutrophil activation — examined transfer factor and the finished formula’s designated endpoints. None of them is a study of the Super-Mushroom Blend. None isolates any mushroom’s contribution. If you want to know what the shiitake in Max did in a person taking Max, the accurate answer is that nobody has published it.

There is one coincidence worth naming precisely so that nobody else dresses it up. Jensen 2026 measured neutrophils — myeloid cells, which are among the cells that carry Dectin-1. That is a coincidence of subject matter. It is not evidence that a mushroom in the formula caused anything, and this page will not present it as such. Our plain-English guide to the three studies sets out what each one actually looked at.

So: four mushrooms, one molecule, one well-characterised human receptor, and a sizeable blank space where the dose data would be. The blank space is the most useful thing on this page. Ingredient lists are easy to admire and hard to interrogate, and a reader who leaves knowing which questions the label cannot answer is better equipped than one who leaves impressed.

Frequently asked questions

Citations & sources

Keep reading

*These statements have not been evaluated by the Food and Drug Administration. Transfer Factor Max and the other products mentioned are dietary supplements and are not intended to diagnose, treat, cure, or prevent any disease. Individual results vary. This article is general science and ingredient education compiled from published sources; it is not medical advice, it is not a description of what any product does in the body, and nothing in it should be taken as a claim that any ingredient affects any disease, symptom or laboratory value. Research on isolated mushroom polysaccharides is described here as history, not as evidence about any dietary supplement. Follow label directions; do not exceed the recommended daily amount. Consult your healthcare provider before beginning any new supplement program, particularly if you take medication, have an autoimmune condition, have a mushroom, mould, egg or dairy allergy, or are pregnant or nursing.